One step towards tailor‐made medicine for patients with heart failure

European Journal of Heart FailureEarly View Invited Editorial One step towards tailor-made medicine for patients with heart failure Ryo Naito, Ryo Naito Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, JapanSearch for more papers by this authorTakatoshi Kasai, Corresponding Author Takatoshi Kasai [email protected] orcid.org/0000-0001-5747-7668 Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan Corresponding author. Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine. 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Tel: +81 3 3813-3111, Fax: +81 3 5689-0627, Email: [email protected]Search for more papers by this author Ryo Naito, Ryo Naito Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, JapanSearch for more papers by this authorTakatoshi Kasai, Corresponding Author Takatoshi Kasai [email protected] orcid.org/0000-0001-5747-7668 Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan Corresponding author. Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine. 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Tel: +81 3 3813-3111, Fax: +81 3 5689-0627, Email: [email protected]Search for more papers by this author First published: 21 June 2023 https://doi.org/10.1002/ejhf.2941 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2892 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596–602. https://doi.org/10.1136/heart.83.5.596 2Naito R, Kasai T. Sodium glucose cotransporter 2 inhibitors: New horizon of the heart failure pharmacotherapy. World J Cardiol 2021; 13: 464–471. https://doi.org/10.4330/wjc.v13.i9.464 3McClellan M, Brown N, Califf RM, Warner JJ. Call to action: Urgent challenges in cardiovascular disease: A presidential advisory from the American Heart Association. Circulation 2019; 139: e44–e54. https://doi.org/10.1161/CIR.0000000000000652 4Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021; 23: 872–881. https://doi.org/10.1002/ejhf.2206 5Musella F, Rosano GMC, Hage C, Benson L, Guidetti F, Moura B, et al. Patient profiles in heart failure with reduced ejection fraction: Prevalence, characteristics, treatments and outcomes in a real-world heart failure population. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2892 Published online ahead of print 21/05/23. 6Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, et al.; G-CHF Investigators. A multinational registry to study the characteristics and outcomes of heart failure patients: The Global Congestive Heart Failure (G-CHF) registry. Am Heart J 2020; 227: 56–63. https://doi.org/10.1016/j.ahj.2020.06.002 7Averbuch T, Sullivan K, Sauer A, Mamas MA, Voors AA, Gale CP, et al. Applications of artificial intelligence and machine learning in heart failure. Eur Heart J Digit Health 2022; 3: 311–322. https://doi.org/10.1093/ehjdh/ztac025 8Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LPC, Foraker RE, et al.; The American Heart Association. Life's Essential 8: Updating and enhancing the American Heart Association's construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation 2022; 146: e18–e43. https://doi.org/10.1161/CIR.0000000000001078 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation